Cargando…

Import of multidrug-resistant bacteria from abroad through interhospital transfers, Finland, 2010–2019

BACKGROUND: While 20–80% of regular visitors to (sub)tropical regions become colonised by extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE), those hospitalised abroad often also carry other multidrug-resistant (MDR) bacteria on return; the rates are presumed to be highest for inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kajova, Mikael, Khawaja, Tamim, Kangas, Jonas, Mäkinen, Hilda, Kantele, Anu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485579/
https://www.ncbi.nlm.nih.gov/pubmed/34596014
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.39.2001360
_version_ 1784577565417013248
author Kajova, Mikael
Khawaja, Tamim
Kangas, Jonas
Mäkinen, Hilda
Kantele, Anu
author_facet Kajova, Mikael
Khawaja, Tamim
Kangas, Jonas
Mäkinen, Hilda
Kantele, Anu
author_sort Kajova, Mikael
collection PubMed
description BACKGROUND: While 20–80% of regular visitors to (sub)tropical regions become colonised by extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE), those hospitalised abroad often also carry other multidrug-resistant (MDR) bacteria on return; the rates are presumed to be highest for interhospital transfers. AIM: This observational study assessed MDR bacterial colonisation among patients transferred directly from hospitals abroad to Helsinki University Hospital. We investigated predisposing factors, clinical infections and associated fatalities. METHODS: Data were derived from screening and from diagnostic samples collected between 2010 and 2019. Risk factors of colonisation were identified by multivariable analysis. Microbiologically verified symptomatic infections and infection-related mortality were recorded during post-transfer hospitalisation. RESULTS: Colonisation rates proved highest for transfers from Asia (69/96; 71.9%) and lowest for those within Europe (99/524; 18.9%). Of all 698 patients, 208 (29.8%) were colonised; among those, 163 (78.4%) carried ESBL-PE, 28 (13.5%) MDR Acinetobacter species, 25 (12.0%) meticillin-resistant Staphylococcus aureus, 25 (12.0%) vancomycin-resistant Enterococcus, 14 (6.7%) carbapenemase-producing Enterobacteriaceae, and 12 (5.8%) MDR Pseudomonas aeruginosa; 46 strains tested carbapenemase gene-positive. In multivariable analysis, geographical region, intensive care unit (ICU) treatment and antibiotic use abroad proved to be risk factors for colonisation. Clinical MDR infections, two of them fatal (1.0%), were recorded for 22 of 208 (10.6%) MDR carriers. CONCLUSIONS: Colonisation by MDR bacteria was common among patients transferred from foreign hospitals. Region of hospitalisation, ICU treatment and antibiotic use were identified as predisposing factors. Within 30 days after transfer, MDR colonisation manifested as clinical infection in more than 10% of the carriers.
format Online
Article
Text
id pubmed-8485579
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-84855792021-10-18 Import of multidrug-resistant bacteria from abroad through interhospital transfers, Finland, 2010–2019 Kajova, Mikael Khawaja, Tamim Kangas, Jonas Mäkinen, Hilda Kantele, Anu Euro Surveill Research BACKGROUND: While 20–80% of regular visitors to (sub)tropical regions become colonised by extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE), those hospitalised abroad often also carry other multidrug-resistant (MDR) bacteria on return; the rates are presumed to be highest for interhospital transfers. AIM: This observational study assessed MDR bacterial colonisation among patients transferred directly from hospitals abroad to Helsinki University Hospital. We investigated predisposing factors, clinical infections and associated fatalities. METHODS: Data were derived from screening and from diagnostic samples collected between 2010 and 2019. Risk factors of colonisation were identified by multivariable analysis. Microbiologically verified symptomatic infections and infection-related mortality were recorded during post-transfer hospitalisation. RESULTS: Colonisation rates proved highest for transfers from Asia (69/96; 71.9%) and lowest for those within Europe (99/524; 18.9%). Of all 698 patients, 208 (29.8%) were colonised; among those, 163 (78.4%) carried ESBL-PE, 28 (13.5%) MDR Acinetobacter species, 25 (12.0%) meticillin-resistant Staphylococcus aureus, 25 (12.0%) vancomycin-resistant Enterococcus, 14 (6.7%) carbapenemase-producing Enterobacteriaceae, and 12 (5.8%) MDR Pseudomonas aeruginosa; 46 strains tested carbapenemase gene-positive. In multivariable analysis, geographical region, intensive care unit (ICU) treatment and antibiotic use abroad proved to be risk factors for colonisation. Clinical MDR infections, two of them fatal (1.0%), were recorded for 22 of 208 (10.6%) MDR carriers. CONCLUSIONS: Colonisation by MDR bacteria was common among patients transferred from foreign hospitals. Region of hospitalisation, ICU treatment and antibiotic use were identified as predisposing factors. Within 30 days after transfer, MDR colonisation manifested as clinical infection in more than 10% of the carriers. European Centre for Disease Prevention and Control (ECDC) 2021-09-30 /pmc/articles/PMC8485579/ /pubmed/34596014 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.39.2001360 Text en This article is copyright of the authors or their affiliated institutions, 2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Research
Kajova, Mikael
Khawaja, Tamim
Kangas, Jonas
Mäkinen, Hilda
Kantele, Anu
Import of multidrug-resistant bacteria from abroad through interhospital transfers, Finland, 2010–2019
title Import of multidrug-resistant bacteria from abroad through interhospital transfers, Finland, 2010–2019
title_full Import of multidrug-resistant bacteria from abroad through interhospital transfers, Finland, 2010–2019
title_fullStr Import of multidrug-resistant bacteria from abroad through interhospital transfers, Finland, 2010–2019
title_full_unstemmed Import of multidrug-resistant bacteria from abroad through interhospital transfers, Finland, 2010–2019
title_short Import of multidrug-resistant bacteria from abroad through interhospital transfers, Finland, 2010–2019
title_sort import of multidrug-resistant bacteria from abroad through interhospital transfers, finland, 2010–2019
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485579/
https://www.ncbi.nlm.nih.gov/pubmed/34596014
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.39.2001360
work_keys_str_mv AT kajovamikael importofmultidrugresistantbacteriafromabroadthroughinterhospitaltransfersfinland20102019
AT khawajatamim importofmultidrugresistantbacteriafromabroadthroughinterhospitaltransfersfinland20102019
AT kangasjonas importofmultidrugresistantbacteriafromabroadthroughinterhospitaltransfersfinland20102019
AT makinenhilda importofmultidrugresistantbacteriafromabroadthroughinterhospitaltransfersfinland20102019
AT kanteleanu importofmultidrugresistantbacteriafromabroadthroughinterhospitaltransfersfinland20102019